Adelaide K. Leitzel, Ph.D is a patent agent whose work focuses on biotechnology and life sciences related patent applications.  She prepares and prosecutes patent applications for innovations from a wide array of life sciences including genetics, transgenic animals, immunology, cardiology, nephrology, diagnostic methods, bacteriology, pulmonology, and biotech methodologies.  Adelaide aids clients in intellectual property strategy development by providing analysis and information related to varying courses of action.  She guides clients in developing international intellectual property decision making matrices.  Adelaide collaborates with attorneys in evaluation of existing patented technologies and patent applications in target portfolios.  Adelaide facilitates attorney understanding of life science technologies and biotechnology life science practices during licensing and contract negotiations.

Adelaide earned her Ph.D in Genetics & Molecular Biology from the University of North Carolina, Chapel Hill.  She then became a patent specialist for the firm of Alston & Bird in Raleigh NC where she aided in preparing and prosecuting patent applications for inventions from additional areas including plant pathology, plant development, transgenic plants, immunology, transgenic animals and genetics.  She is a registered patent agent and practiced with Taft, Stettinius & Hollister for many years.